What's in Averitas Pharma, Inc.'s pipeline?

Averitas Pharma, Inc. has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Averitas Pharma, Inc.'s portfolio?

Top competitors by shared drug class: M.D. Anderson Cancer Center, NeurogesX, The University of Texas Health Science Center, Houston, University Hospital, Clermont-Ferrand, Women and Infants Hospital of Rhode Island.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/averitas-pharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Averitas Pharma, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Averitas Pharma, Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Capsaicin 8%	Capsaicin 8%	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)	Pain Management
capsaicin 0.04% topical system	capsaicin 0.04% topical system	phase 3

Therapeutic area mix

Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

M.D. Anderson Cancer Center · 1 shared drug class
NeurogesX · 1 shared drug class
The University of Texas Health Science Center, Houston · 1 shared drug class
University Hospital, Clermont-Ferrand · 1 shared drug class
Women and Infants Hospital of Rhode Island · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Averitas Pharma, Inc.:

Cite this brief

Drug Landscape (2026). Averitas Pharma, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/averitas-pharma-inc. Accessed 2026-05-16.